Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals Inc.

SUPN | NASDAQ
Chart Builder DCF Calculator
$42.78
+$0.78 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$42.78
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$2.48B
Enterprise Value
$2.15B
Beta
0.56
Average Volume
808.98K
Shares Outstanding (Diluted)
58.07M
Shares Change YoY
2.52%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US8684591089

Price Performance

Price Change 1M
-6.1%
Price Change 3M
-3.8%
Price Change 6M
-14.5%
Price Change YTD
-13.5%
Price Change 1Y
-8.9%
Price Change 3Y
51.9%
Price Change 5Y
53.8%
1M CAGR (ann.)
-10.2%
1Y CAGR (ann.)
-7.3%
5Y CAGR (ann.)
9.7%
All-Time CAGR
15.5%

Valuation

PE Ratio
-22.28
Forward PE
9.86
PEG Ratio
0.21
Forward PEG
-0.30
PS Ratio
2.99
Forward PS
1.80
PB Ratio
2.41
P/FCF Ratio
132.16
P/Adj. FCF Ratio
-63.33
P/OCF Ratio
125.82
EV/Sales
2.59
EV/EBIT
-18.29
EV/EBITDA
-135.56
EV/FCF
114.50
Earnings Yield
-4.5%
FCF Yield
0.8%
Adj. FCF Yield
-1.6%

Financial Health

Net Cash
$361.32M
Total Debt
$40.17M
Cash & Short-Term Investments
$372.07M
Total Assets
$1.43B
Current Ratio
2.08
Quick Ratio
1.84
Debt / Equity Ratio
0.04
Debt / EBITDA
-2.53
Debt / FCF
2.14
OCF / Debt
0.50
Interest Coverage
-48.30
Altman Z-Score
4.83
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
88.1%
Operating Profit Margin
-13.5%
EBITDA Margin
-1.9%
Net Profit Margin
-13.2%
FCF Margin
2.3%
Adj. FCF Margin
-4.7%
SBC / Revenue
7.0%
SBC Impact (per share)
-308.7%

Returns

Return on Assets
-7.7%
Return on Equity
-10.4%
Return on Invested Capital
-9.1%
Return on Capital Employed
-10.3%
Return on Tangible Assets
-13.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
9.4%
Revenue CAGR 5Y
7.8%
Revenue CAGR 10Y
16.9%
EPS CAGR 3Y
-446.3%
EPS CAGR 5Y
-255.8%
EPS CAGR 10Y
-30.0%
FCF CAGR 3Y
-36.1%
FCF CAGR 5Y
-30.8%
FCF CAGR 10Y
-4.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
132.3%
Revenue Growth Next 3Y
30.3%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.61
EPS Growth Est (next Q)
-39.1%
Revenue Est (next Q)
$218.29M
Revenue Growth Est (next Q)
13.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$57.60
Price Target Upside
34.6%

Cash Flow

Operating Cash Flow
$19.91M
Free Cash Flow
$18.79M
Adj. Free Cash Flow
$-39.21M
FCF Per Share
$0.32
OCF Per Share
$0.34
OCF/S Ratio
2.4%

Income Statement

Revenue
$830.44M
Gross Profit
$731.41M
Operating Income
$-111.81M
EBITDA
$-15.87M
Net Income
$-109.89M
EPS (Diluted)
-$1.92
Revenue / Employee
$1.07M
Profit / Employee
$-141.24K
Employees
778

© 2026 bestshares.com. All rights reserved.